Adaptimmune Announces Changes to Board of Directors

NEXT STORY
Targovax strengthens Board of Directors with the appointment of Catherine Wheeler
PREV STORY
Paratek Pharmaceuticals Presenting New Data from Omadacycline Development Program at ECCMID 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche and Illumina partner to broaden patient access to genomic testing

author_avatar
NASDAQ Market News

Fermion’s new plant operational in Hanko – nearly 100% of production is exported

Orion Corporation   Press release 14 June 2018 at 9.00 a.m. Fermion's new plant operational ...

author_avatar
NASDAQ Market News

Theratechnologies annonce l’approbation par la FDA de la percée thérapeutique TROGARZO(MC) (ibalizumab-uiyk) injection, le premier inhibiteur du VIH-1 et premier anticorps monoclonal à action prolongée contre le VIH-1 multi-résistant aux traitements existants

Premier traitement du VIH avec un nouveau mécanisme d’action approuvé en plus de 10 ...

author_avatar
NASDAQ Market News